As the main objective in CSC research is to devise new means to effectively and selectively eliminate CSCs,30 our present work is focused on the combination of CD47 and CD133 as a potential predictor for ESCC patients, to further distinguish CSCs, and ultimately eliminating these malignant cells. The gene discussed is PROM1; the disease is esophageal squamous cell carcinoma.